v3.20.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Operating expenses:        
Research and development $ 8,259 $ 7,080 $ 22,864 $ 19,932
General and administrative 3,292 2,601 9,018 7,413
Total operating expenses 11,551 9,681 31,882 27,345
Loss from operations (11,551) (9,681) (31,882) (27,345)
Interest income 262 533 1,081 1,837
Net loss $ (11,289) $ (9,148) $ (30,801) $ (25,508)
Net loss per common share, basic and diluted $ (0.23) $ (0.48) $ (0.73) $ (1.34)
Weighted-average shares used to compute net loss per common share, basic and diluted 49,999,239 19,095,870 41,964,042 19,070,937

Source